Schouten out as Johnston made Mucosis CEO
This article was originally published in Scrip
Executive Summary
Dutch biotech Mucosis has made Thomas Johnston CEO, succeeding Govert Schouten who has left the company to found an internet start-up. Mr Johnston joined the company as chief business officer in May 2011 having previously served as vice-president of strategy at Novavax.